Does Nebivolol Prevent Contrast-Induced Nephropathy in Humans?

Creative Commons License

Gunebakmaz O., KAYA M., Koc F., Akpek M., Kasapkara A., İNANÇ M. T., ...More

CLINICAL CARDIOLOGY, vol.35, no.4, pp.250-254, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 4
  • Publication Date: 2012
  • Doi Number: 10.1002/clc.21013
  • Journal Name: CLINICAL CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.250-254
  • Erciyes University Affiliated: Yes

Abstract

Background: An experimental study showed that nebivolol is an effective agent in contrast-induced nephropathy (CIN) prophylaxis.